The hepatitis C virus was once a hard to treat,
chronic disease. Now we can fight the disease in specific genotypes
with treatments such as direct-acting antivirals, but it will take
both science and society to make elimination possible for all
patients. We’re working to remove barriers that prevent people from
getting care, with the goal of helping reduce new infections by 90
percent over the next 11 years.